| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 19, 2005
Accepted on July 29, 2005
Department of Molecular and Structural Biochemistry, Box 7622, North Carolina State University, Raleigh, NC 27695-7622; Department of Toxicology, Box 7633, North Carolina State University, Raleigh, NC 27695-7633
* To whom correspondence should be addressed. E-mail: wlmiller{at}ncsu.edu.
Follicle stimulating hormone (FSH), a key regulator of gonadal function, contains a
subunit (FSH
) that is transcriptionally induced by activin, a member of the transforming growth factor
(TGF
) superfamily. This study used 4.7 kb of the ovine FSH
promoter linked to luciferase (oFSH
Luc) plus a well characterized activin-responsive construct, p3TPLuc, to investigate the hypothesis that Smad3, TAK1 (TGF
activated kinase1), or both cause activin-mediated induction of FSH. Over-expression of either Smad3 or TAK1 induced oFSH
Luc in gonadotrope-derived L
T2 cells as much as activin itself. Induction of p3TPLuc by activin is known to require Smad3 activation in many cell types and this was true in L
T2 cells where 10-fold induction by activin (2-8 h after activin treatment) was blocked > 90% by two dominant negative (DN) inhibitors of Smad3 [DN-Smad3 (3SA) and DN-Smad3 (D407E)]. By contrast, 6.5-fold induction of oFSH
Luc by activin (10-24 h after activin treatment) was not blocked by either DN-Smad inhibitor, suggesting that activation of Smad3 did not trigger induction of oFSH
Luc. By contrast, inhibition of TAK1 by a DN-TAK1 construct led to a 50% decrease in activin-mediated induction of oFSH
Luc, and a specific inhibitor of TAK1 (5Z-7-Oxozeanol) blocked induction by 100% indicating that TAK1 is necessary for activin induction of oFSH
Luc. Finally, inhibiting p38-mitogen activated protein kinase (p38-MAPK; often activated by TAK1) blocked induction of oFSH
Luc by 60%. In conclusion, the data presented here indicate that activation of TAK1 (and probably p38-MAPK), but not Smad3, is necessary for triggering induction of oFSH
by activin.
This article has been cited by other articles:
![]() |
P. Lamba, V. Khivansara, A. C. D'Alessio, M. M. Santos, and D. J. Bernard Paired-Like Homeodomain Transcription Factors 1 and 2 Regulate Follicle-Stimulating Hormone {beta}-Subunit Transcription through a Conserved cis-Element Endocrinology, June 1, 2008; 149(6): 3095 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. G. Thackray and P. L. Mellon Synergistic Induction of Follicle-Stimulating Hormone {beta}-Subunit Gene Expression by Gonadal Steroid Hormone Receptors and Smad Proteins Endocrinology, March 1, 2008; 149(3): 1091 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Haisenleder, L. L. Burger, H. E. Walsh, J. Stevens, K. W. Aylor, M. A. Shupnik, and J. C. Marshall Pulsatile Gonadotropin-Releasing Hormone Stimulation of Gonadotropin Subunit Transcription in Rat Pituitaries: Evidence for the Involvement of Jun N-Terminal Kinase But Not p38 Endocrinology, January 1, 2008; 149(1): 139 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Coss, C. M. Hand, K. K. J. Yaphockun, H. A. Ely, and P. L. Mellon p38 Mitogen-Activated Protein Kinase Is Critical for Synergistic Induction of the FSH{beta} Gene by Gonadotropin-Releasing Hormone and Activin through Augmentation of c-Fos Induction and Smad Phosphorylation Mol. Endocrinol., December 1, 2007; 21(12): 3071 - 3086. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B Lee, V. Khivansara, M. M Santos, P. Lamba, T. Yuen, S. C Sealfon, and D. J Bernard Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone {beta} subunit transcription J. Mol. Endocrinol., February 1, 2007; 38(2): 315 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Guise, A. Lacerte, S. Rafiei, R. Reynaud, M. Roy, T. Brue, and J.-J. Lebrun Activin Inhibits the Human Pit-1 Gene Promoter through the p38 Kinase Pathway in a Smad-Independent Manner Endocrinology, September 1, 2006; 147(9): 4351 - 4362. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |